[artículo]
| Título : |
Weight change and metabolic effects of asenapine in patients with schizophrenia and bipolar disorder |
| Tipo de documento: |
texto impreso |
| Autores: |
David E. Kemp, Autor ; Jun Zhao, Autor ; Pilar Cazorla, Autor |
| Fecha de publicación: |
2022 |
| Artículo en la página: |
pp. 238-245 |
| Idioma : |
Inglés (eng) Idioma original : Inglés (eng) |
| Palabras clave: |
Antipsicóticos, Benzodiazepinas, Trastorno bipolar, Índice de masa corporal, Colesterol LDL, Ensayos clínicos controlados, Olanzapina, Esquizofrenia, Triglicéridos. |
| Resumen: |
To describe weight changes and metabolic effects of asenapine compared with placebo and olanzapine in adults.
Post hoc analyses were performed using data from 17 asenapine trials (13 schizophrenia and 4 bipolar mania trials) with placebo (5-10 mg twice daily; n = 1,748; 1-6 weeks) and/or olanzapine (5-20 mg, once daily; n = 3,430; 3-100 weeks). |
| Link: |
./index.php?lvl=notice_display&id=27809 |
in The Journal of Clinical Psychiatry > Año 2014 - Vol.75 - No.3 (Marzo) . - pp. 238-245
[artículo] Weight change and metabolic effects of asenapine in patients with schizophrenia and bipolar disorder [texto impreso] / David E. Kemp, Autor ; Jun Zhao, Autor ; Pilar Cazorla, Autor . - 2022 . - pp. 238-245. Idioma : Inglés ( eng) Idioma original : Inglés ( eng) in The Journal of Clinical Psychiatry > Año 2014 - Vol.75 - No.3 (Marzo) . - pp. 238-245
| Palabras clave: |
Antipsicóticos, Benzodiazepinas, Trastorno bipolar, Índice de masa corporal, Colesterol LDL, Ensayos clínicos controlados, Olanzapina, Esquizofrenia, Triglicéridos. |
| Resumen: |
To describe weight changes and metabolic effects of asenapine compared with placebo and olanzapine in adults.
Post hoc analyses were performed using data from 17 asenapine trials (13 schizophrenia and 4 bipolar mania trials) with placebo (5-10 mg twice daily; n = 1,748; 1-6 weeks) and/or olanzapine (5-20 mg, once daily; n = 3,430; 3-100 weeks). |
| Link: |
./index.php?lvl=notice_display&id=27809 |
|
Weight change and metabolic effects of asenapine in patients with schizophrenia and bipolar disorder en The Journal of Clinical Psychiatry, Año 2014 - Vol.75 - No.3 (Marzo)
